250 related articles for article (PubMed ID: 17018593)
1. Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis.
Balsitis S; Dick F; Dyson N; Lambert PF
Cancer Res; 2006 Oct; 66(19):9393-400. PubMed ID: 17018593
[TBL] [Abstract][Full Text] [Related]
2. High level HPV-16 E7 oncoprotein expression correlates with reduced pRb-levels in cervical biopsies.
Fiedler M; Müller-Holzner E; Viertler HP; Widschwendter A; Laich A; Pfister G; Spoden GA; Jansen-Dürr P; Zwerschke W
FASEB J; 2004 Jul; 18(10):1120-2. PubMed ID: 15155561
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis.
Shin MK; Balsitis S; Brake T; Lambert PF
Cancer Res; 2009 Jul; 69(14):5656-63. PubMed ID: 19584294
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
5. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities.
Shai A; Brake T; Somoza C; Lambert PF
Cancer Res; 2007 Feb; 67(4):1626-35. PubMed ID: 17308103
[TBL] [Abstract][Full Text] [Related]
6. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.
Wu L; Goodwin EC; Naeger LK; Vigo E; Galaktionov K; Helin K; DiMaio D
Mol Cell Biol; 2000 Oct; 20(19):7059-67. PubMed ID: 10982822
[TBL] [Abstract][Full Text] [Related]
7. Examination of the pRb-dependent and pRb-independent functions of E7 in vivo.
Balsitis S; Dick F; Lee D; Farrell L; Hyde RK; Griep AE; Dyson N; Lambert PF
J Virol; 2005 Sep; 79(17):11392-402. PubMed ID: 16103190
[TBL] [Abstract][Full Text] [Related]
8. Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene.
Jabbar SF; Abrams L; Glick A; Lambert PF
Cancer Res; 2009 May; 69(10):4407-14. PubMed ID: 19435895
[TBL] [Abstract][Full Text] [Related]
9. Recapitulation of the effects of the human papillomavirus type 16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo.
Balsitis SJ; Sage J; Duensing S; Münger K; Jacks T; Lambert PF
Mol Cell Biol; 2003 Dec; 23(24):9094-103. PubMed ID: 14645521
[TBL] [Abstract][Full Text] [Related]
10. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
[TBL] [Abstract][Full Text] [Related]
11. Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer.
Chung SH; Wiedmeyer K; Shai A; Korach KS; Lambert PF
Cancer Res; 2008 Dec; 68(23):9928-34. PubMed ID: 19047174
[TBL] [Abstract][Full Text] [Related]
12. Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice.
Park S; Park JW; Pitot HC; Lambert PF
mBio; 2016 May; 7(3):. PubMed ID: 27190216
[TBL] [Abstract][Full Text] [Related]
13. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
[TBL] [Abstract][Full Text] [Related]
14. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
[TBL] [Abstract][Full Text] [Related]
15. High incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins.
Park JW; Shin MK; Lambert PF
Oncogene; 2014 Jun; 33(26):3383-91. PubMed ID: 24013229
[TBL] [Abstract][Full Text] [Related]
16. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells.
Jiang B; Xue M
Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278
[TBL] [Abstract][Full Text] [Related]
17. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene.
Herber R; Liem A; Pitot H; Lambert PF
J Virol; 1996 Mar; 70(3):1873-81. PubMed ID: 8627712
[TBL] [Abstract][Full Text] [Related]
18. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
19. WAPL induces cervical intraepithelial neoplasia modulated with estrogen signaling without HPV E6/E7.
Kumagai K; Takanashi M; Ohno SI; Harada Y; Fujita K; Oikawa K; Sudo K; Ikeda SI; Nishi H; Oikawa K; Kuroda M
Oncogene; 2021 May; 40(21):3695-3706. PubMed ID: 33947962
[TBL] [Abstract][Full Text] [Related]
20. Human papilloma virus (HPV) and cervical cancer.
Furumoto H; Irahara M
J Med Invest; 2002 Aug; 49(3-4):124-33. PubMed ID: 12323001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
